Jan 14, 2025 · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty g

Sep 20, 2024 · The FTC’s administrative complaint alleges that CVS Health’s Caremark, Cigna’s ESI, and United Health Group’s Optum, and their respective GPOs—Zinc Health Services, Ascent Health Services, and Emisar Pharma Services—have abused their economic power by rigging pharmaceutical supply chain competition in their favor, forcing patients ...

January 17, 2025 This week FTC staff filed petitions to enforce compliance with civil investigative demands (“CIDs”) the FTC issued to The Cigna Group (“Cigna”) and CVS Health Corporation (“CVS”) more than a year ago. The CIDs were issued as part of an investigation into the potentially unlawful pharmacy-related business practices of the healthcare conglomerates that own the three ...

Jan 14, 2025 · Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion in revenue, The Federal Trade Commission (FTC) said in a report...

Jan 14, 2025 · FTC said the "Big 3 PBMs" — CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to thousands of percent on critical drugs, including those for...

Jan 14, 2025 · Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more than $7.3 billion in “excess” revenue over six years, the Federal Trade Commission said in a report on the drug middlemen.

Sep 20, 2024 · The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a system that...

Oct 9, 2024 · Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

Sep 21, 2024 · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.